On August 12, Cytosorbents Corp (OTCBB:CTSO) published the 10-Q covering the second quarter of 2014. Back then, the stock was sitting at $0.30 and in light of the decent figures presented by the report,...
Cytosorbents Corp (OTCBB:CTSO) has been on a wild ride over the last few months. First, in August, the ticker jumped because of some analyst coverage and positive Q2 results. It peaked at $0.30, but...
After moving within the confines of 10-13 cents per share for nearly the entire 2013 the stock of Cytosorbents Corp (OTCBB:CTSO) is currently making one impressive run up the chart. In just four sessions...
Cyto Sorbents, Corp. (OTCBB:CTSO) is spiking on record volumes, growing by more than 23% on Thursday, to 15 cents, as buying reached above $711,000. CTSO rises without the benefit of a promotion, though it...
Innovative therapies are a risky bet where acceptance in the medical community and a marketing network can make or break a company. The most recent seller of futuristic healthcare, CytoSorbents Corporation (OTC:CTSO) reminded of...